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ABSTRACT
Background. Sentinel node biopsy (SNB) for cN0 early
squamous cell carcinoma (SCC) of the oral cavity has been
validated by numerous studies. Around 30% of SNB will
detect occult disease. Several clinical and morphological
features of the primary tumor have been claimed to be
predictive for occult metastasis in elective neck dissec-
tions. The aim of this study was to assess these factors in
the context of SNB.
Methods. Seventy-eight patients undergoing SNB for T1/2
oral SCC from the years 2000 to 2007 were prospectively
included. Primary tumors were reviewed for the following
morphological and clinical parameters: grade of differen-
tiation, tumor depth, tumor thickness, perineural invasion,
lymphatic invasion, vascular invasion, muscle invasion,
lymphoplasmacytic infiltration, and mode of invasion, age,
gender, primary tumor site, tumor side, and cT category.
Results. Statistical analysis revealed significance to predict
occult metastasis in the SNB for grade of differentiation
(P = 0.002), lymphatic invasion (P \ 0.001), and mode of
invasion (P \ 0.001). None of the other factors reached
significance. The mean tumor depth was 6.45 mm (range
0.72–15.15 mm) and the mean tumor thickness was 7.2 mm
(range 0.72–15.15 mm). None of the cutoff values reached
significance for predicting occult disease.
Conclusions. Tumor depth and tumor thickness failed to
achieve statistical significance for prediction of occult
metastases in the context of SNB. Patients with cN0 early
squamous cell carcinoma of the oral cavity should be
offered SNB regardless of their tumor depth and thickness.
Poorly differentiated carcinomas, carcinomas with lymp-
hangiosis, and carcinomas with a dissolute mode of invasion
show a high probability of positive SNB.
Lymph node metastases have been shown to be the
strongest prognosticator in head and neck squamous cell
carcinoma (HNSCC). The 5-year survival drops consider-
ably from 63–86% in patients with no nodal involvement
to 20–36% in patients with lymph node metastases.1–4
Whereas therapeutic neck dissection in patients with overt
lymph node involvement is considered standard of care,
there still exists controversy with regard to elective treat-
ment of the clinically negative neck. Though the benefit of
elective neck dissection versus wait-and-see with thera-
peutic neck dissection in case of nodal relapse has never
been proven in large randomized trials, most centers around
the world favor an active policy in these situations. The
rationale for this lies in the high prevalence of occult dis-
ease found on routine elective neck dissection. However,
although 20–30% of clinically N0 patients will show occult
metastases on elective neck dissection, a considerably large
number of patients will remain pathologically N0, and
therefore do not benefit from the surgical intervention.5,6
During the last decade sentinel node biopsy (SNB) has been
adopted from the treatment of breast cancer and melanoma,
and successfully introduced in the treatment regimen of
early oral and oropharyngeal squamous cell carcinoma.7–11
Many studies in the context of elective neck dissections
have investigated potential predictive factors for lymph
node metastasis in clinically nodal negative patients,
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with contradictory results, most probably due to insuffi-
cient histopathological workup of the neck dissection
specimens.14–45
The most promising factor emerging from these studies
seemed to be the depth of tumor infiltration.14–16,20–33 Even
nowadays, many centers still rely on cutoff values of 4 or
5 mm of tumor depth for indication of elective neck treat-
ment. With regard to the much more focused and precise
histological staging of sentinel lymph nodes in contrast to
nodes in neck dissection specimens, the aim of this study
was to assess whether any of the formerly evaluated clinical
or histologic factors in the primary tumors were still sig-
nificantly predictive of occult disease in the context of SNB.
PATIENTS AND METHODS
Patients
Between the years 2000 and 2007 the total number of 78
patients with biopsy-proven early-stage (cT1/2) SCC of the
oral cavity and no evidence of lymph node metastases (cN0)
after physical examination and adequate imaging were
prospectively enrolled in our SNB protocol. All patients
underwent transoral tumor resection and SNB as previously
published.9 Patient data were retrieved from the archives of
the Department of Otorhinolaryngology—Head and Neck
Surgery, University Hospital Zurich, Switzerland. Matched
tissue samples from excision specimens were retrieved from
the archives of the Institute of Surgical Pathology, Uni-
versity Hospital Zurich, Switzerland. All diagnoses were
reviewed by an experienced pathologist. The study was
approved by the local ethics committee.
From an extensive literature review, all the clinical and
histomorphologic parameters associated with potential
predictive significance were extracted.
The following clinical parameters were included in the
statistical analysis: age, gender, anatomic subsite of the
primary tumor (floor of mouth versus oral tongue), tumor
side (right, left, midline), and cT category.12
Histopathology
The entire sentinel nodes were examined with conven-
tional hematoxylin and eosin (H&E) and immunohis-
tochemical cytokeratin (CK) staining at step-serial sections
of 150-lm intervals as published earlier.9 The exact meth-
odology of SNB has been previously described.13 The
sentinel nodes were categorized as either positive in case of
the presence of any occult cancer deposits (isolated tumor
cells and/or micrometastasis and/or metastasis) or as neg-
ative if no tumor cells were detected.46
The primary tumor was routinely stained with H&E. The
following histopathological features of the tumor and its
microenvironment were examined: grade of differentiation
(G1–3), tumor depth, tumor thickness, perineural invasion,
lymphatic invasion, vascular invasion, muscle invasion,
peritumoral lymphoplasmacytic infiltration, and mode of
invasion.
Grade of differentiation (GOD) was routinely assessed
depending on the degree of keratinization, nuclear poly-
morphism, and the number of mitoses, lymphatic (LI) or
vascular (VI) as well as muscle (MI) and perineural inva-
sion (PI) as described in the literature.12,15–17
For the statistical analysis tumors graded G1 were com-
pared with the pooled tumors graded G2 and 3.
Tumor depth and tumor thickness were assessed with
the aid of a computerized image analysis program (analy-
SISD soft imaging system, Olympus Company, Tokyo/
Japan) linked to a light microscope (Zeiss Axiophot micro-
scope, Oberkochen/Germany). Tumor depth and thickness
were defined and measured according Ambrosch et al. as
follows:14 Tumor depth was measured vertically from the
mucosal surface to the deepest point of tumor infiltration. If
there was no mucosal surface due to ulceration or exo-
phytic growth a virtual mucosa line connecting the adjacent
mucosal surface of both sides was used. Tumor thickness
was assessed by drawing a parallel line to the virtual
mucosa line, placed tangentially at the most exophytic
tumor area. Whereas the starting points differed for the two
measurements, the deepest point of the invasive tumor
border was identical for both.
The entire tumor specimen was investigated, and the
tumor section with the most important tumor depth and
thickness was photographed under the light microscope, and
the images digitalized on a computer. The image analysis
program then calculated the corresponding tumor thickness
and depth values.
The extent of peritumoral lymphoplasmacytic infiltration
(LPI) was divided into three grades according to Brandw-
ein-Gensler et al.18 A decreasing number of infiltrating
lymphocytes has been shown to parallel a worse biological
outcome. Grade 1 is characterized by a continuous dense
layer of lymphoplasmacytic infiltration among tumor and
healthy tissue. Grade 2 shows a discontinuous patchy pat-
tern of lymphoplasmacytic infiltration. Grade 3 shows only
minimal or no infiltration.
For statistical analysis, tumors with grade 1 (low-risk
group) were compared with the pooled grade 2 and 3 tumors
(high-risk group).
The mode of invasion (MOI) describes the morphologi-
cal appearance of the infiltrating tumor front. According to
the grading system of Yamamoto et al., the higher the MI
grade, the more aggressive the infiltrating pattern.19 MI
grade 1 describes a well-defined tumor front. MI grade 2
tumors have a less well-defined front with plump cords in
part. In MI grade 3 tumors no distinct border is identifiable
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anymore; however, dissolute groups of infiltrating tumor
cells are predominating. MI Grade 4 is characterized by a
diffuse type of invasion with two subgroups: MI subtype 4C
(Fig. 1) shows a cord-like type of diffuse invasion, whereas
in MI subtype 4D a widespread type of diffuse invasion
prevails. Of note, only the deepest region of the tumor was
assessed, as there were differences in the mode of invasion
between the superficial and deep fraction of the tumor.
For statistical analysis, grades 1–3 were pooled as low-
risk group (cohesive growth pattern) and compared with
the pooled grade 4 tumors (dissolute growth pattern).
Statistical Methods
In order to explore the relation between clinical and
histopathologic parameters and the occurrence of sentinel
lymph node metastasis (SLNM), first the chi-squared test
for the categorical variables and the Mann–Whitney test for
the continuous variables were applied. These tests were
used to detect dependencies between possible predictive
factors and the outcome variable.
In a second step, all variables were tested in univariate
logistic regression models. These models enable the quan-
tification of the influence of the predictive variables on the
outcome.
For illustration purposes, the sensitivity, specificity, and
positive and negative predictive values for the parameters
were calculated. For continuous variables, the receiver
operating characteristic (ROC) curve displays the sensi-
tivity and 1—specificity for all possible threshold values.
Therefore it is a valuable tool for the evaluation of possible
diagnostic markers.
All calculations were carried out using SPSS version
16.0.2 software for Mac OS X (SPSS Inc., Chicago, IL).
Figures 3 and 4 were produced using the statistical
software R version 2.7.2 for Mac OS X (The R foundation
for Statistical Computing). Values of P \ 0.05 were con-
sidered as statistically significant.
RESULTS
Clinical Parameters
A total of 78 patients (52 males, 26 females) with a
mean age of 60 years (range 34–87 years) were included in
this study. The site of primary tumor origin was the oral
tongue in 55 and the floor of mouth in 23 patients. The
tumors were staged T1 in 40 and T2 in 38 patients. SNB
revealed occult disease in 28 patients (36%), whereas 50
patients (64%) remained nodal negative. The primary
tumor was on the right side in 40, on the left side in 32, and
in the midline in 6 patients.
Table 1 summarizes the results of the clinical parame-
ters assessed as potential predictive factors for occult
disease in the sentinel lymph nodes. None of the clinical
parameters were statistically significant for the prediction
of SLNM.
Histopathologic Parameters
The distribution of the histopathologic parameters
between tumors with and without SLNM, and the Pear-
son’s chi-squared test or, respectively, the Mann–Whitney
test, is summarized in Table 2. There were three highly
significant parameters correlating with the occurrence of
SLNM in the logistic regression model: grade of differ-
entiation (G1 versus G2/3), lymphatic invasion, and mode
of invasion (cohesive versus dissolute). Poor differentia-
tion, dissolute growth pattern at the infiltrating tumor front,
FIG. 1 Example of a dissolute infiltration pattern grade 4C at the
tumor front (H&E)
TABLE 1 Clinical parameters
Parameter SLNM? SLNM- P Valuea
Gender
Men 18 34 0.739
Women 10 16
Anatomic subsite
Floor of mouth 8 15 0.894
Oral tongue 20 35
Tumor side
Right 13 27 0.686
Left 12 20
Midline 3 3
cT category
cT1 14 26 0.865
cT2 14 24
a Pearson’s chi-squared test
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and lymphatic invasion were significantly associated with
higher likelihood of SLNM. All primary tumors with
lymphatic invasion showed SLNM. In contrast, no tumor
graded as well differentiated (G1) showed SLNM. All the
other parameters were not significant.
Table 3 presents the sensitivity, specificity, positive and
negative predictive value, odds ratio with 95% confidence
interval, and the p value of the univariate logistic regression
analysis of the histologic parameters. Mode of invasion
revealed the highest odds ratio among all histomorphologic
criteria. Only 3 of 48 patients (6.3%) in the low-risk group
with cohesive growth pattern showed a SLNM. In contrast,
25 of 30 patients (83.3%) in the high-risk group with
dissolute growth pattern had SLNM. Accordingly, the false-
negative rate was very small, and the sensitivity and
negative predictive value reached 89.3% and 93.8%,
respectively.
Additional cross-tabulations of the parameters mode of
invasion versus grade of differentiation and lymphatic
invasion, respectively, were used to detect dependencies.
The P-value of Fisher’s exact test for MOI versus GOD
was 0.006 and for MOI versus LI was 0.011, showing a
considerable connection between these parameters.
The measurement of tumor depth and tumor thickness in
the primary tumors revealed an average value of 6.45 and
7.2 mm, respectively, with a range of 0.72–15.15 and 0.72–
15.15 mm, respectively.
In Table 4, different cutoff values for tumor depth in
relation to the corresponding sensitivity, specificity, posi-
tive and negative predictive value (NPV), odds ratio with
95% confidence interval, and P value of the univariate
logistic regression analysis are listed. The same values are
given for the tumor thickness in Table 5.
None of the cutoff values, for neither tumor depth nor
tumor thickness, achieved statistical significance to predict
SLNM. For the tumor depth even the cutoff values of 1 and
2 mm, respectively, only reached a NPV of 75%. The most
widely used cutoff values of 3, 4, and 5 mm were only able
to exclude SLNM in roughly two-thirds of cases. For tumor
thickness the cutoff values of 1 and 2 mm reached a NPV of
100%, and the cutoff of 3 mm reached a NPV of 80%. The
most widely used cutoff values of 4 and 5 mm were again
only able to exclude SLNM in roughly two-thirds of cases.
Probably the best statistical method to analyze the pre-
dictive significance of a tested parameter is a ROC curve
with calculation of the area under the curve. A steep curve
with a large area under the curve represents a very reliable
diagnostic test, whereas a curve approximating a diagonal
indicates a diagnostic test which is completely inappropri-
ate, because its results are not better than results obtained by
chance or guessing. Figures 2 and 3 show the ROC curves
for tumor depth and tumor thickness, respectively. The
values of the area under the curve for tumor depth and
tumor thickness were 0.539 and 0.527, respectively. It is
very obvious that neither of these parameters is useful to
predict SLNM.
Figures 4 and 5 show the percentage of patients with
SLNM divided into groups of 1 mm from 1 to 16 mm for
tumor depth/thickness. Each group contains the number of
patients for whom tumor depth/thickness values were in the
range of the group limits. In each group the prevalence of
the SLNM-positive patients was calculated and showed no
TABLE 2 Distribution and significance of histopathological
parameters
Parameter SLNM? SLNM– P valuea
Grade of differentiation
G1 0 15 0.002
G2 20 30
G3 8 5
Lymphatic invasion
Positive 10 0 \0.001
Negative 18 50
Mode of invasion
Grade 1 0 11 \0.001
Grade 2 0 12
Grade 3 3 22
Grade 4C 14 2
Grade 4D 11 3
Perineural invasion
Positive 6 9 0.712
Negative 22 41
Vascular invasion
Positive 2 1 0.257
Negative 26 49
Muscle invasion
Positive 22 33 0.243
Negative 6 17
Lymphoplasmacytic infiltration
Grade 1 9 22 0.515
Grade 2 16 25
Grade 3 3 3
Tumor depth, mm
0–4.99 11 21 0.567
5.00–9.99 9 20
10.00–14.99 7 9
15.00–19.99 1 0
Tumor thickness, mm
0–4.99 9 15 0.692
5.00–9.99 11 25
10.00–14.99 7 10
15.00–19.99 1 0
a Pearson’s chi-squared test, Mann–Whitney test for tumor depth and
thickness
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TABLE 3 Analysis of histopathologic parameters
Sensitivity, % Specificity, % PPV, % NPV, % Odds ratio 95% CI P valuea
Differentiation 100 30 44.4 100 na na na
Lymphatic invasion 35.7 100 100 73.5 na na na
Mode of invasion 89.3 90 83.3 93.8 75 16.5–340.4 \0.001
Perineural invasion 21.4 82 40 65.1 1.2 0.4–4.0 0.713
Vascular invasion 7.1 98 66.7 65.3 3.8 0.3–43.6 0.288
Muscle invasion 78.6 34 40 73.9 1.9 0.6–5.5 0.247
LPI 67.9 44 40.4 71.0 1.7 0.6–4.4 0.307
a Univariate logistic regression
TABLE 4 Statistics of cutoff values for tumor depth
Cutoff, mm Sensitivity, % Specificity, % PPV, % NPV, % Odds ratio 95% CI P valuea
1 96.4 6 36.5 75 1.7 0.2–17.4 0.645
2 92.9 12 37.1 75 1.8 0.3–9.4 0.502
3 85.7 16 36.4 66.7 1.1 0.3–4.2 0.841
4 64.3 32 34.6 61.5 0.8 0.3–2.2 0.739
5 60.7 42 37.0 65.6 1.1 0.4–2.9 0.815
6 46.4 62 40.6 67.4 1.4 0.6–3.6 0.469
a Univariate logistic regression
TABLE 5 Statistics of cutoff values for tumor thickness
Cutoff, mm Sensitivity, % Specificity, % PPV, % NPV, % Odds ratio 95% CI P valuea
1 100 4 36.8 100 na na na
2 100 6 37.3 100 na na na
3 96.4 8 37.0 80 2.3 0.2–22.1 0.456
4 78.6 20 35.5 62.5 0.9 0.3–2.9 0.881
5 67.9 30 35.2 62.5 0.9 0.3–2.5 0.844
6 53.6 48 36.6 64.9 1.1 0.4–2.7 0.894
a Univariate logistic regression
1.0
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0.2
1.00
1 - Specificity
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FIG. 2 ROC curve for tumor depth
1.0
0.8
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ROC Curve Tumor Thickness
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Sensitivity
FIG. 3 ROC curve for tumor thickness
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linear correlation between increasing values of tumor depth
or tumor thickness and the proportion of patients with
SLNM.
DISCUSSION
During the last decade SNB has been validated for the
treatment of early oral and oropharyngeal SCC by a wide
range of validation trials throughout the world. The pri-
mary goal of SNB is a more accurate histopathologic
staging of the clinically and radiologically negative neck.
This goal is achieved by meticulous workup of the sentinel
nodes with step-serial sectioning and staining with immu-
nohistochemistry. This type of workup exceeds by far the
routine possible workup of entire elective neck dissection
specimens. Elective neck dissection has been routinely
applied to the majority of patients presenting with early
oral and oropharyngeal SCC due to the 20–30% incidence
of occult disease. Numerous studies have tried to reduce
the number of unnecessary elective neck dissections by
evaluating potential prognostic markers. The most prom-
ising markers predicting occult disease were thought to be
tumor thickness and infiltration depth. Many centers,
therefore, based their decision to perform elective neck
dissections on cutoff values of 4 or 5 mm in tumor
thickness or tumor depth. These two values seemed to
correlate with the occurrence of occult disease. The aim of
our study was to evaluate all parameters investigated for
potential prediction of occult disease in elective neck dis-
sections within the context of SNB.
Several clinical parameters, such as gender, anatomic
subsite, and cT category, were assessed in our study. None
of them reached statistical significance for prediction of
occult metastases. This means that T1 and T2 tumors, and
tumors arising from the floor of mouth and the oral tongue,
respectively, have the same risk for occult nodal disease.
Bilde et al. in a comparable study also failed to find a
correlation between T stage, tumor site, and nodal metas-
tases.47 This is in contrast to the report of Alkureishi et al.,
who found a correlation between T stage and the occur-
rence of nodal disease.48 However, in their study larger
tumors staged from T1 to T4 and tumors arising from the
oropharynx were included. Their figures show a risk of
upstaging by SNB for T1 and T2 tumors of approximately
30% and 50%, and for T3 and T4 tumors of approximately
75% and 80%, respectively. So, the big difference is not
between T1 and T2, but between T1/2 and T3/4. If only early
tumors had been included, the T stage would possibly not
have been prognostic anymore. As the consensus nowadays
is that SNB should be reserved for early SCC staged T1 or
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FIG. 4 Tumor depth in relation to prevalence
of SLNM
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FIG. 5 Tumor thickness in relation to
prevalence of SLNM
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T2, T stage, in our opinion, cannot be used as a predictor
for occult nodal disease.
In previous studies, a great variety of histomorphologic
parameters have been investigated as potential markers of
occult disease. All these studies were performed in the
context of elective neck dissection. To our knowledge, this
is the first study evaluating a broad spectrum of histomor-
phologic parameters for prediction of occult nodal disease
in SNB. Out of this large number of histomorphologic
parameters only GOD (G2/3 versus G1), LI, and MOI
(dissolute versus cohesive) were significantly associated
with SLNM.
Whereas none of the patients with G1 tumors were found
to harbor SLNM, the PPV for a high-risk GOD (G2/3)
reached 44.4%. This result is in agreement with several
previously published studies. Pimenta Amaral et al. repor-
ted the GOD to be significantly predictive in floor-of-mouth
and T2 tumors.
17 Also reports by Kurokawa et al., Byers
et al., Sparano et al., and Martı´nez-Gimeno C et al. found a
significant correlation between a poorly differentiated car-
cinoma and the presence of occult nodal metastases in the
neck dissection specimen.21,29,33,37 In a particular study by
Chen et al. the prevalence of nodal metastases in the elec-
tive neck dissections was 32% for well and 75% for poorly
differentiated carcinomas.38 In the study by Bilde et al.
there was no correlation between GOD and the detection of
occult nodal disease by SNB.47 In contrast to our study, in
their study most patients presented with well (47%) or
moderately (43%) differentiated SCC. As nodal disease was
mainly associated with a poor GOD, this might explain the
difference between the two studies.
All patients in our study with LI were diagnosed with
SLNM (100% PPV). A highly significant association
between the presence of lymphovascular invasion and
nodal metastases in elective neck dissections was also
shown in studies by Shingaki et al., Pimenta Amaral et al.,
Brown et al., and Sparano et al.16,17,24,29
Another strong predictor for SLNM in our study was a
dissolute growth pattern at the infiltrating tumor front, with
PPV of 83.3% and odds ratio of 75. The histologic assess-
ment and classification of the mode of invasion is not easy
and warrants effort and experience from the pathologists. In
our study grades 1, 2, and 3 were pooled as a low-risk group,
in contrast to grade 4 as a high-risk group. Only 3 out of 48
(6.25%) patients in the low-risk group, but 25 out of 30
(83.33%) patients of the high-risk group, revealed SLNM.
This result is in agreement with the original description by
Yamamoto et al., and underlines the accuracy of the clas-
sification system for MOI.19 Various other studies by
Kurokawa et al., Osaki et al., Nagata et al., and Okamoto
et al. came to the same conclusions.21,39–41 Further statis-
tical analysis of the significant parameters GOD, LI, and
MOI showed a clear interdependency of these three
parameters, which means that patients with poorly differ-
entiated SCC have a higher likelihood of a dissolute, and
therefore more aggressive, infiltration pattern, and likewise
a higher probability of lymphatic infiltration, which in
summary ends up in a significantly higher rate of SLNM.
None of the other histomorphologic parameters assessed
in our study were significantly predictive for SLNM. For the
parameter perineural invasion this result is in contradiction
with some studies.22,24,29,33,35,42 However, it is in agree-
ment with quite a number of other studies.15,17,23,31,37 The
parameter vascular invasion is also reported controversially
in the literature. As in our study, many others failed to
reveal a significant predictive value.15,23,27,35,43 However,
others were able to do so.16,17,21,22,29,33,42 For the parameter
muscle invasion there is only the report by Pimenta Amaral
et al. showing an association with nodal metastases.17 The
reports for the parameter lymphoplasmacytic infiltration are
again controversial in the literature. Some reports support
its predictive value.16,44 However, more do not.15,31,33,35 In
summary, none of the parameters perineural invasion,
vascular invasion, muscle invasion, or lymphoplasmacytic
infiltration can be used as a predictive factor for occult
nodal disease.
In contradiction to the results published for elective neck
dissections neither tumor thickness nor tumor depth was
significantly associated with SLNM.14–16,20–33 There was no
linear correlation between increasing tumor thickness or
tumor depth and the rate of SLNM. It is widely accepted that
elective neck treatment is justified if the risk of occult dis-
ease exceeds 15–20%. For this reason, Ambrosch et al. and
Kurokawa et al. suggested a cutoff value of 4 mm, and Kane
et al. and Fukano et al. of 5 mm for tumor depth.14,15,20,25
Accordingly, tumors with an infiltration depth of 4 or 5 mm,
respectively, and more should be treated with elective neck
dissection, whereas for thinner tumors a wait-and-watch
policy can be advocated. In our study, for the parameter
tumor depth even a cutoff value of 1 mm reached only a
NPV of 75%. For tumor thickness the NPV was 100% for
the cutoff value of 2 mm, but only 80% for 3 mm. This
means that also patients with very thin and superficial
tumors should undergo elective neck treatment due to a
significant risk for occult disease. Statistical analysis with
ROC curves clearly showed that neither of the two values
(tumor depth or tumor thickness) can be used as a reliable
predictor for occult disease. This result not only stands in
contradiction to the previously published results in the
context of elective neck dissection, but also in contradiction
to the reports in the context of SNB by Alkureishi et al. and
Bilde et al.47,48 In the study by Alkureishi et al. tumors up to
stage T4 and oropharyngeal tumors with significantly higher
values of tumor depth were included.48 The mean tumor
depth was 7.85 mm with a wide range of 1–28 mm, whereas
the corresponding values in our study achieved 6.45 mm
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and 0.72–15.15 mm, respectively. As in their manuscript
the risk for occult disease for oral cavity SCC exceeds 20%
at a cutoff value of 5 mm, the authors suggest a cutoff of
5 mm as reasonable. Unfortunately, no NPV are calculated.
The authors, however, admit that none of the examined
cutoff values reaches a satisfactory sensitivity and speci-
ficity. In the study by Bilde et al. the mean values for tumor
thickness and tumor depth were comparable to ours.47 The
incidence of nodal metastases as published in the erratum
was 58% for tumors thicker or deeper infiltrating than
4 mm. Therefore, the authors conclude a cutoff of 4 mm to
be reliable. Unfortunately, no statistics are given for other
cutoff values, which renders comparison with our study
difficult.
CONCLUSION
In this study, we were able to assess all clinical and
histomorphologic parameters of primary tumors in the oral
cavity potentially predictive for the occurrence of occult
disease within the context of SNB. GOD, LI, and MOI
showed a statistically significant correlation with the
appearance of SLNM. Therefore, patients with poorly
differentiated tumors, lymphatic infiltration, and dissolute
tumor pattern at the infiltrating tumor front have a high
likelihood of SLNM. Patients with LI and a dissolute MOI
might benefit from upfront elective neck dissection due to
the very high likelihood of occult disease in the SNB.
Increasing tumor thickness and tumor depth showed no
correlation with the rate of SLNM and no statistically
significant prediction of occult disease. Therefore, these
two parameters and their different cutoff values should not
be used for the decision to treat the neck electively or not.
Patients with early SCC of the oral cavity should undergo
SNB for accurate staging of the cN0 neck irrespective of
the values of tumor thickness and tumor depth.
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